Technical Analysis for MPH - Medicure Inc.

Grade Last Price % Change Price Change
D 1.150 -4.17% -0.050
MPH closed down 4.17 percent on Thursday, March 28, 2024, on 30 percent of normal volume.
Earnings due: Apr 4
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.17%
Narrow Range Bar Range Contraction -4.17%
Wide Bands Range Expansion -4.17%
MACD Bullish Signal Line Cross Bullish -4.17%
Pocket Pivot Bullish Swing Setup -4.17%
Volume Surge Other -4.17%
Outside Day Range Expansion -4.17%

   Recent Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Medicure Inc. Description

Medicure Inc. (Medicure) is a pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. The Company operates in the biopharmaceutical industry segment. The Company's primary operating focus is on the sale and marketing of its acute care cardiovascular drug, AGGRASTAT (tirofiban hydrochloride) owned by its subsidiary, Medicure International, Inc. and distributed in the United States and its territories through the Company's United States subsidiary, Medicure Pharma, Inc. AGGRASTAT, a glycoprotein IIb/IIIa inhibitor (GPI), is used for the treatment of acute coronary syndrome (ACS). The Company is also engaged in the development of TARDOXAL for neurological disorders, such as Tardive Dyskinesia (TD). The Company has completed Phase IIa stage of development for TARDOXAL. The Company is also developing Transdermal AGGRASTAT, a cure for acute cardiology. Transdermal AGGRASTAT is in preclinical-stage of development.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Chemistry Marketing Medicine Pharma Pharmaceutical Clinic Drug Skin Organ Systems Biopharmaceutical Disorders Pharmaceutical Industry Cardiology Neurological Disorders

Is MPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.8
52 Week Low 0.93
Average Volume 5,033
200-Day Moving Average 1.311
50-Day Moving Average 1.329
20-Day Moving Average 1.205
10-Day Moving Average 1.141
Average True Range 0.071
RSI (14) 45.36
ADX 9.15
+DI 35.007
-DI 48.433
Chandelier Exit (Long, 3 ATRs) 1.237
Chandelier Exit (Short, 3 ATRs) 1.253
Upper Bollinger Bands 1.409
Lower Bollinger Band 1.001
Percent B (%b) 0.37
BandWidth 33.909
MACD Line -0.051
MACD Signal Line -0.060
MACD Histogram 0.0099
Fundamentals Value
Market Cap 12.02 Million
Num Shares 10.5 Million
EPS -0.18
Price-to-Earnings (P/E) Ratio -6.53
Price-to-Sales 0.79
Price-to-Book 0.32
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.150
Resistance 3 (R3) 1.150 1.150 1.150
Resistance 2 (R2) 1.150 1.150 1.150 1.150
Resistance 1 (R1) 1.150 1.150 1.150 1.150 1.150
Pivot Point 1.150 1.150 1.150 1.150 1.150
Support 1 (S1) 1.150 1.150 1.150 1.150 1.150
Support 2 (S2) 1.150 1.150 1.150 1.150
Support 3 (S3) 1.150 1.150 1.150
Support 4 (S4) 1.150